Participated in Trellis Bioscience's $9M raise to advance a Phase 2 trial of a monoclonal antibody for prosthetic joint infections.
Trellis Bioscience is focused on developing innovative therapies targeting bacteria, viruses, and cancer through advanced scientific research and technology
Trellis Bioscience is focused on developing innovative therapies targeting bacteria, viruses, and cancer through advanced scientific research and technology.